Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Briacell Therapeutics Corp T.BCT

Alternate Symbol(s):  BCTX | BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.


TSX:BCT - Post by User

Bullboard Posts
Comment by ValueHunter92on Mar 31, 2016 9:11am
113 Views
Post# 24714457

RE:Big things coming

RE:Big things comingMy name is Dr Schreibe
;I posted 2-3 days ago about the fact that the latest news represent an tremendous increase in company value du to the medical implications.As mentionned on

 Although BriaCell's promising results to date have been achieved in late-stage breast cancer patients, the Company recognizes that its technology may be applicable to certain other similar solid cancers as well. The protocol submitted to the FDA for BriaCell's upcoming clinical trial thus has formal provision to allow testing of BriaVax™ in selected patients with other cancers aside from breast

I did consult my friend witch is an old senior inspector a FDA (actually retired), and after he has investigated this, he beleive their is high chance of buy out from major. Reasons is when FDA give chance to spread from initial goal, is because proofs has been made and verified, by several sources on several cases.

Therefore, I acknowledged from others post that most of option were at 25cent, so the resistance should hold from there and bounce over 40-75cent.

Finally, I repeat that I do beleive, with 23 yrs of experience as a Phd Pharmaco-Biologist for Pfizer, that this news is a serious candidate for takeout

I must declare that i Invested 35 000$ over the last twos days, firmly beleiving I will tripple up or more my investment.

PS: THe conference the 18 april, as others mentionned, is more medical than commercial purposes, but still their is financials shark arounds looking for incredible opportunity to be faster than others to jump in, the company will soar the 19-20-21, mark my word, if not way sooner

Dr Shreiber, I will be out around 60 cent - 70 cent in fews day, people who readed the entire text will understands and hopefully remember

S
Bullboard Posts